Search results
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 3 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Lung cancer treatment produces progression-free survival results in Phase III trial
Medical Xpress· 5 hours agoIn a recent study led by Suresh Ramalingam, MD, executive director of Winship Cancer Institute of Emory University, a new drug has shown remarkable promise ...
New lung cancer pill could ‘stop disease in its tracks’
Daily Telegraph· 5 days agoPatients with an incurable form of lung cancer could lead normal lives by taking a daily pill that...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 1 day agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 5 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 5 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Lung cancer wonder drug hailed as study shows 'off the chart' survival benefit
Daily Express· 5 days agoResults from a trial of daily pill lorlatinib were described as "unprecedented".
Catching cancer early lowers risk of mortality, but screening is the first step
Stacker via AOL· 3 hours agocancer in their lifetime, and 1 in 39 women will die from it. In self-reported data, Black women are...
Summit Shares Soar After Lung Cancer Drug Tops Keytruda in Study
Bloomberg· 6 days agoSummit Therapeutics Inc. shares jumped after the biotech company said a late-stage trial met its...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 2 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...